Table 1.

Demographic features of the study subjects

Group	No. of subjects	Mean age	% of male	% of genotype 1	HCV RNA (IU/ml)	Medications used for HCV treatment
HCV-infected patients	36	53 (31–69)	96	70	23 000–50 000 000	N/A
HCV-treated patients (SVR)	8	53	100	N/A	N/A	PegIFN + RBV ± Boceprevir
Healthy subjects	19	47	84	N/A	N/A	N/A

HCV, hepatitis C virus; N/A, not applicable; PegIFN, pegylated interferon; RBV, ribavirin; SVR, sustained virological response.